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Worldwide, hepatocellular carcinoma (HCC) occurs mainly in Asian patients with
hepatitis B virus (HBV) infection. This study aimed to decipher the environmental and
virological factors associated with HCC occurrence and validate risk scoring systems
in a French multicentre prospective cohort of HBV cirrhotic patients. Patients with
biopsy-proven Child-Pugh A viral cirrhosis included in the ANRS CO12 CirVir cohort
who were HBsAg(+) without hepatitis C coinfection were selected for: (a) interview
through a standardized questionnaire reporting coffee consumption and HCC familial
history; (b) HBsAg quantification using baseline and sequential 2-year frozen sera; (c)
baseline HBV genotype determination; and (d) assessment of risk factors and
applicability of HCC risk scores (Kaplan-Meier analysis, Cox models). Among 317
patients studied (261 men, median age 53 years, past or ongoing antiviral treatment
93.3% and baseline detectable HBV DNA in 88 patients), the baseline and 2-year
median HBsAg levels were 810 and 463 IU/mL, respectively. After a median follow-up
of 65.2 months, 27 HCC cases were diagnosed (annual incidence: 1.6%). Three
factors were independently associated with HCC occurrence: age > 50 years,
platelets ≤ 150 × 10 /mm and body mass index ≥ 30 kg/m . Two out of five risk scores
were validated, and the most accurate was PAGE-B at 1 year. Moreover, HCC in
patients without maintained virological suppression seems more aggressive and less
accessible to curative treatment. In conclusion, in French patients with HBV cirrhosis
mostly virally suppressed, independent HCC risk factors were host-related (age,
obesity) or linked to the severity of cirrhosis (thrombopenia), and the European
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